In a recent interview, WIN member and general cardiologist Dr. Janneke Wittekoek of the Netherlands summarizes how men and women differ with respect to the manifestation and management of cardiovascular disease (CVD), and discusses the implications for clinical practice.
The interview covers:
Our current understanding of sex-related differences in CVD.
How these differences manifest in clinical practice.
How the perceptions of patients and clinicians can influence management.
Sex differences in the efficacy of certain cardiovascular interventions.
How to help ensure that men and women receive appropriate cardiovascular care.
To read the full article and watch the interview video, click on the article link below.
A variety of US government agencies are more actively turning their attention towards women and heart disease.
The Heart Truth is a national awareness and prevention campaign about heart disease in women sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health of the U.S. Department of Health and Human Services.
While the Heart Truth campaign has a long standing public partnership with Diet Coke, the campaign more recently developed a useful set of online clinical education tools and resources for both physicians and their patients including fact sheets, downloads, slides and free CME credit for physicians and nurses. To access the toolkit, click HERE.
The US Food and Drug Administration’s Office of Women’s Health is also actively working to address gender disparities in cardiovascular care. To access the OWH’s extenstive research efforts in this area, along with their own set of public resources, click HERE.
Below is the FDA OWH’s Public Safety Announcement regarding women and heart attack symptoms. An important message to share!
The American Heart Association (AHA) recently released a statement in the February, 2012 issue of its Circulation journal highlighting the burden of peripheral artery disease (PAD) in the female population. The statement indicates that not only do more women than men suffer from PAD, but their symptoms are often atypical.
The statement, titled “A Call to Action: Women and Peripheral Artery Disease” recommends that both public and physician education on these issues is necessary. In fact, a recent survey showed that 75% of adults had no awareness of PAD as a disease, and those at highest risk for PAD (the elderly and minorities) were the least informed.
As women and heart disease continues to be at the forefront of national and global concern, PAD will no doubt become a priority. To read the full AHA statement, click HERE.
The Journal of the American Medical Association recently published study results which indicate that the proportion of MI patients who present without chest pain is significantly higher for women than men. Researchers in the study examined predictors of MI presentation without chest pain and the relationship between age, sex, and hospital mortality.
Reporting their findings in “Circulation,” published online February 12, 2012, Dr Abigail Fraser (University of Bristol, UK) and colleagues found that women who had had gestational diabetes or preeclampsia during pregnancy had about a 30% increased risk of CVD after 18 years of follow-up, based on the Framingham Risk Score (FRS), compared with those who had not had these complications.
Theses findings add weight to WIN’s patient screening project with Abbott Vascular’s Women’s Heart Health Initiative, which links OBGYNs and cardiologists to better identify women with symptoms of heart disease. Preliminary results from the screening effort will be presented as abstracts at both ACC ’12 and SCAI ’12.
WIN is a world-wide effort devoted to improving the overall approach to the medical treatment of women with cardiovascular disease, as well as increasing the quality and scope of professional and educational opportunities offered to female interventional cardiologists.